Definitive Contract HR001121C0135
Award Date
4/15/21
Potential Completion Date
2/14/22
Potential Value
$224K
Federal Agency
Defense Advanced Research Projects Agency
Awardee
Autonomous Healthcare Inc.
Ultimate Awardee
Not listed
PSC Category
AC12 - National Defense R&D Services; Department Of Defense - Military; Applied Research
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hoboken, NJ 07030, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to JSL Innovations LLC, a small business, for the development of an Automated Hemorrhage Control Device. The contract has a ceiling value of $218,930.00 and a period of performance ending on March 25, 2022. The award was made on May 28, 2021 under a Broad Agency Announcement that sought proposals for SBIR and Small Business Technology Transfer (STTR) funding...
This is a $1,249,946.00 Small Business Innovation Research (SBIR) Phase II award from the Defense Advanced Research Projects Agency (DARPA) to CCJ Medical Devices LLC, a veteran-owned limited liability company located in Asheville, North Carolina. The contract is for the development of an "Automated Partial Occlusion for Truncal Hemorrhage Control" technology, which was solicited under DARPA's Broad Agency Announcement for SBIR and Small Business Technology Transfer (STTR)...
This is a $3,902,011.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Boundless Science Inc., a small business located in Durham, North Carolina. The contract is for the development of a "Novel Blood Oxygenation Device to Save Warriors on the Battlefield" under the Small Business Innovation Research (SBIR) Program Phase II. The contract has a period of performance ending on August 2, 2026. This award is designated as a Total Small...
This Small Business Innovative Research (SBIR) Phase II contract, awarded by the Defense Advanced Research Projects Agency (DARPA), provides $1,499,308 to Creare LLC for the development of a smart REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) catheter. The contract has a completion date of June 5, 2025 and is set aside for small businesses. As part of this effort, Creare is collaborating with Dartmouth-Hitchcock Clinic to support cadaveric and in vivo animal testing of the...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Air Force Research Laboratory to Autonomus Medical Technologies, Inc. for the "ENABLING RAPID TREATMENT OF NONCOMPRESSIBLE HEMORRHAGE BY A NON-SPECIALIST IN AUSTERE ENVIRONMENTS USING THE ARTIFICIAL INTELLIGENCE GUIDED ULTRASOUND INTERVENTION DEVICE (AI-GUIDE)" project. The firm-fixed-price contract has a ceiling value of $74,134.00 and a period of performance through August 7, 2023. The contract...
This is a $11,374,956.00 firm-fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Critical Innovations LLC, a small business medical research and development company, to provide services in accordance with the statement of work. The contract has no set-aside designation and is based on a pre-solicitation for innovative proposals to develop intravascular gas-exchange and trauma resuscitation devices that can enable management of polytrauma...
This is a firm fixed price purchase order contract awarded by the Air Force Research Laboratory to Daxor Corporation, a small disadvantaged business, for the Far Forward and En Route Decision Assist in the Treatment of Hemorrhage under the Small Business Innovation Research (SBIR) Program Phase II. The contract has a ceiling value of $749,967.00 and is set to expire on August 15, 2024. Daxor Corporation, the prime contractor, is a medical instrumentation and biotechnology company that provides...
This is a $1,649,996.73 firm-fixed-price contract awarded by the Defense Health Agency (DHA) to Daxor Corporation, a self-certified small disadvantaged business, for Phase II of the Small Business Innovation Research (SBIR) program. The contract, with a period of performance from July 2023 to November 2025, is for research and development related to hemorrhage treatment and blood volume analysis technologies to support combat casualty care. This contract is a set-aside for small businesses and...
This federal contract award was issued by the Defense Health Agency (DHA) to Hybrid Plastics, Incorporated, a for-profit manufacturer, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $999,997.59, is for the development of a "Hemostatic Agent" under the DHA PHASE II SBIR H2-0265 project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance is from the award date of September 15, 2017...
This is a $1,701,323.05 cost-plus-fixed-fee DARPA SBIR Phase II contract awarded to Optofluidics Inc. (doing business as Halo Labs) for the development of "Point of Injury" sampling technology for battlefield molecular diagnostics. The contract was set aside for small businesses and has an ultimate completion date of September 30, 2015. The contracting agency is the U.S. Army Aviation and Missile Command, which is a defense agency. This SBIR Phase II contract is likely part of...